INVO Bioscience, Inc. Form 8-K Summary
Business Context and Reporting Period
INVO Bioscience, Inc. (trading symbol: INVO) filed this Current Report on Form 8-K on March 30, 2021. The filing serves to announce the Company's financial results for the fiscal year ended December 31, 2020. The Company is incorporated in Nevada and maintains its principal executive offices in Sarasota, Florida.
Key Financial Metrics
The filing text provided does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are referenced as being detailed in the press release furnished as Exhibit 99.1, which is not included in the source text.
Material Changes
No specific material changes versus the prior comparable period are quantified in the provided text. The filing indicates that the Company issued a press release regarding its 2020 results, but the specific variances are not disclosed in the 8-K body.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer stating that the information in Item 2.02 and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, this information is not incorporated by reference into other Company filings unless expressly stated. No specific guidance, outlook, or risk factors are detailed in the provided text.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated March 30, 2021) for specific revenue, net loss, and cash position figures for the year ended December 31, 2020.
- Verify the Company's liquidity status and cash burn rate as detailed in the full press release.
- Confirm any updates to the Company's product pipeline or regulatory milestones mentioned in the excluded exhibit.
- Check subsequent filings for any incorporation of the 2020 results into formal financial statements.